As biologicals become truly mainstream in global agriculture, they must demonstrate their ability to solve real problems and deliver consistent value. Season after season, crop after crop. Growers increasingly understand the promise of biologicals, but widespread adoption depends on products that perform reliably, integrate seamlessly into existing programs, and offer a measurable return on investment.

This belief is central to Acadian Plant Health (APH) as the company looks toward 2026. Building on the strong momentum of its Abiotic Stress Management (ASM) portfolio, APH will introduce its next major platform, the Soil Health Management (SHM) portfolio, designed to elevate traditional biostimulant products through advanced formulation and evidence-based innovation.

“Biologicals will only become mainstream if they deliver real, repeatable value,” says Nelson Gibson, CEO of Acadian. “Our role is not to rely on tradition, but to evolve it. Advancing seaweed-based solutions through rigorous science and formulation that meets the standards the agricultural industry expects from any modern agricultural input.”

2025 Strengthened the Foundation. 2026 Builds the Future.

Throughout 2025, Acadian Plant Health’s Abiotic Stress Management (ASM) platform continued to mature, moving beyond early concept validation into broader field evaluation and advanced commercial readiness.

But for Gibson, 2026 represents the next stage in a bigger, long-term transformation of the biological category.

“Growers are ready for biologicals. What they need now are biologicals that behave like advanced agricultural technologies,” he explains. “That means better design, better consistency, and better performance.”

Bringing the Best Science Together

What sets APH apart in the biologicals industry is not only its decades of leadership in seaweed-based biostimulant science, but also the company’s integration of seaweed extract experts, biostimulant, crop protection and plant nutrition specialists with formulation chemists.

This combined expertise allows APH to move beyond the limits of traditional seaweed extracts and create enhanced, purpose-built biological solutions engineered for modern farming systems.

“It’s the intersection of natural bio-actives and advanced formulation science where we create the most value,” says Gibson. “We bring the best of biological and formulation thinking into one innovation engine.”

A New Soil Health Management Portfolio

Acadian’s new Soil Health Management (SHM) portfolio is built on the principle that healthier, biologically active soil drives both immediate and lasting benefits. In the short-term, the strengthened ecosystem with the soil helps crops become more resilient and protects yield. In the long-term, protecting and enriching the soil itself – laying the foundation for regenerative agriculture and a more productive, sustainable future.

These solutions do more than deliver traditional seaweed extract benefits; they represent a new generation of formulated biologicals tailored for long-term soil function and regenerative agriculture.

“Soil health is where biologicals can make some of their biggest contributions,” Gibson notes. “And our new portfolio is designed to offer soil solutions that perform just as consistently as any mainstream agricultural technology.”

Elevating Traditional Extracts Through Innovation and Formulation

Instead of relying on extraction alone, APH is redefining what a seaweed-derived biological can be through advanced formulation science, bioactive enhancement, and rigorous validation. This approach moves biologicals to a new level.

“We’re taking a trusted natural resource and building something more advanced on top of it,” Gibson explains. “That’s how you turn biologicals from niche inputs into essential tools for modern agriculture.”

Because of this, APH has strengthened numerous strategic partnerships across the agricultural value chain. These collaborations continue into 2026 and support APH’s commitment to delivering high-quality biologicals at global scale.

“Our partners see the reliability of our supply chain and the strength of our science,” says Gibson. “That’s why our technologies are increasingly part of mainstream crop strategies around the world.”

Leading the Future of Biologicals—Through Performance

APH sees 2026 as a defining moment, not only for the company, but for the biologicals category. The world is ready for biologicals, but it is performance, not promises, that will determine their place in future agriculture.

“We’re here to raise the bar for biologicals,” Gibson concludes. “If we want biologicals to be truly mainstream, they must work. And work consistently. That’s the standard we’re building for 2026 and beyond.”

Find out more about our solutions here or contact us Contact Us directly.